Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Lakeland Financial Corp
LKFN
$1.56B
| $1.47M | ﹤0.01% |
32,502
-100,621
| -76% | -$4.59M |
|
2602
National Vision
EYE
$1.79B
| $1.47M | ﹤0.01% |
46,705
+34,785
| +292% | +$1.09M |
|
|
VBIV
2603
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $1.47M | ﹤0.01% |
26,123
+889
| +4% | +$48.1K |
|
|
MSON
2604
DELISTED
Misonix Inc
MSON
| $1.46M | ﹤0.01% |
+76,099
| New | +$1.44M |
|
|
ACER
2605
DELISTED
Acer Therapeutics Inc
ACER
| $1.46M | ﹤0.01% |
+59,892
| New | +$1.41M |
|
|
VISN
2606
Vistance Networks Inc
VISN
$2.64B
| $1.45M | ﹤0.01% |
66,772
-737,827
| -92% | -$15.5M |
|
|
PGNX
2607
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.45M | ﹤0.01% |
312,635
-236,318
| -43% | -$1.07M |
|
2608
PUT
Ball Corp
BALL
$17.4B
| $1.45M | ﹤0.01% |
25,000
-100,000
| -80% | -$5.33M |
|
2609
Hyster-Yale Materials Handling
HY
$600M
| $1.45M | ﹤0.01% |
+23,187
| New | +$1.57M |
|
2610
CALL
IQVIA
IQV
$39.1B
| $1.44M | ﹤0.01% |
10,000
-5,000
| -33% | -$666K |
|
|
ROCC
2611
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.44M | ﹤0.01% |
+32,619
| New | +$1.75M |
|
2612
CALL
Edwards Lifesciences
EW
$50B
| $1.44M | ﹤0.01% |
22,500
-36,000
| -62% | -$2.05M |
|
2613
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $1.43M | ﹤0.01% |
33,700
-27,262
| -45% | -$1.12M |
|
|
HI
2614
DELISTED
Hillenbrand
HI
| $1.43M | ﹤0.01% |
34,459
-18,555
| -35% | -$783K |
|
|
VAR
2615
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.43M | ﹤0.01% |
10,100
+100
| +1% | +$13.1K |
|
2616
Granite Construction
GVA
$5.03B
| $1.43M | ﹤0.01% |
+33,090
| New | +$1.47M |
|
2617
OFG Bancorp
OFG
$2.22B
| $1.43M | ﹤0.01% |
71,998
-164,285
| -70% | -$3.18M |
|
2618
HCA Healthcare
HCA
$85.7B
| $1.42M | ﹤0.01% |
10,906
-212,061
| -95% | -$28.5M |
|
2619
iShares MSCI USA Quality Factor ETF
QUAL
$46.3B
| $1.42M | ﹤0.01% |
16,040
+8,000
| +100% | +$673K |
|
|
FARO
2620
DELISTED
Faro Technologies
FARO
| $1.42M | ﹤0.01% |
32,214
-7,627
| -19% | -$337K |
|
2621
HNI Corp
HNI
$3.14B
| $1.42M | ﹤0.01% |
38,987
-5,808
| -13% | -$223K |
|
2622
TriCo Bancshares
TCBK
$1.85B
| $1.42M | ﹤0.01% |
36,008
-9,031
| -20% | -$341K |
|
2623
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
| $1.42M | ﹤0.01% |
1,095
-1,291
| -54% | -$1.67M |
|
2624
InflaRx
IFRX
$253M
| $1.41M | ﹤0.01% |
37,368
-34,785
| -48% | -$1.3M |
|
2625
PUT
Intuit
INTU
$86.3B
| $1.41M | ﹤0.01% |
+5,400
| New | +$1.25M |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.